BIO and a string of CEOs issue a call for FDA independence and against science-by-press-release
It appears to be open letter week in biotech.
On Sunday, Scripps Research’s Eric Topol penned a scathing letter in Medscape calling for FDA commissioner Stephen Hahn to resign after a series of alleged missteps and political concessions. And today, in a carefully-worded piece, the head of BIO and eight well-known biotech CEOs issued a call for the FDA’s independence and for biotechs — with the world spotlight on them — to be on their best behavior.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 144,300+ biopharma pros reading Endpoints daily — and it's free.